- Home
- GAU vs TKNO Comparison
GAU vs TKNO Comparison
Compare GAU & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAU
- TKNO
- Stock Information
- Founded
- GAU 1999
- TKNO 1996
- Country
- GAU Canada
- TKNO United States
- Employees
- GAU N/A
- TKNO N/A
- Industry
- GAU
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- GAU
- TKNO Health Care
- Exchange
- GAU Nasdaq
- TKNO Nasdaq
- Market Cap
- GAU 339.1M
- TKNO 390.7M
- IPO Year
- GAU N/A
- TKNO 2021
- Fundamental
- Price
- GAU $1.23
- TKNO $7.73
- Analyst Decision
- GAU Strong Buy
- TKNO Buy
- Analyst Count
- GAU 2
- TKNO 2
- Target Price
- GAU $3.43
- TKNO $5.00
- AVG Volume (30 Days)
- GAU 524.6K
- TKNO 206.5K
- Earning Date
- GAU 02-13-2025
- TKNO 11-07-2024
- Dividend Yield
- GAU N/A
- TKNO N/A
- EPS Growth
- GAU N/A
- TKNO N/A
- EPS
- GAU N/A
- TKNO N/A
- Revenue
- GAU $166,788,000.00
- TKNO $36,347,000.00
- Revenue This Year
- GAU N/A
- TKNO $3.47
- Revenue Next Year
- GAU $67.18
- TKNO $12.07
- P/E Ratio
- GAU N/A
- TKNO N/A
- Revenue Growth
- GAU N/A
- TKNO N/A
- 52 Week Low
- GAU $0.65
- TKNO $1.16
- 52 Week High
- GAU $2.00
- TKNO $8.91
- Technical
- Relative Strength Index (RSI)
- GAU 36.88
- TKNO 51.60
- Support Level
- GAU $1.19
- TKNO $7.00
- Resistance Level
- GAU $1.34
- TKNO $8.89
- Average True Range (ATR)
- GAU 0.06
- TKNO 0.74
- MACD
- GAU -0.01
- TKNO -0.09
- Stochastic Oscillator
- GAU 14.58
- TKNO 38.24
About GAU Galiano Gold Inc.
Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages the Asanko Gold Mine, located in Ghana, West Africa. Its Asanko Gold Mine is a multi-deposit complex, with two main deposits, the Obotan Project and the Esaase Project, both located in the Amansie West District of the Republic of Ghana, West Africa.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.